November 11, 2014Gynecological Endocrinology

Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes

View Full Paper

Ask AI

Bookmark

Abstract

Co-administration of GnRH-agonist and hCG for final oocyte maturation, 40 and 34 h prior to OPU, respectively (double trigger) improves IVF outcome in patients with high proportion of immature oocytes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zilberberg et al. (2014) studied this question.

synapsesocial.com/papers/69dd4ca37808b00a4799c69e https://doi.org/10.3109/09513590.2014.978850

View Full Paper

Ask AI

Bookmark

Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes

Abstract

Discussion

Cite This Study

Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes

Abstract

Discussion

Cite This Study

Also Consider

Also Consider